IRBS — IR BioSciences Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for IR BioSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.44 | 5.52 | 5.02 | 3.13 | 8.29 |
| Operating Profit | -1.44 | -5.52 | -5.02 | -3.13 | -8.29 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.49 | -5.45 | -5.81 | -6.46 | -5.28 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.49 | -5.46 | -5.81 | -6.46 | -5.28 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.49 | -5.46 | -5.81 | -6.46 | -5.28 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -1.49 | -5.46 | -5.81 | -6.46 | -5.41 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.341 | -0.478 | -0.491 | -0.49 | -0.119 |
| Dividends per Share |